Product Description
Thiotepa Injection is a must-have antineoplastic solution, renowned for its Champion efficacy in cancer care. Each affordable, single-dose glass vial contains 15 mg preservative-free Thiotepa, meeting Unparalleled USP standards. Reserved for intravenous, intravesical, or intraperitoneal use, this stellar cytotoxic agent is packaged securely and clearly labeled with batch details, expiry, and product code. Specially designed for chemotherapy in ovarian, breast, and bladder cancers, it features neutral pH, white lyophilized powder and is odorless. Handle with PPE due to its cytotoxic nature. Trusted by distributors, exporters, and healthcare professionals across India.
Who Uses Thiotepa Injection and Its Application
Thiotepa Injection is widely used by oncologists, healthcare professionals, and hospital pharmacies for chemotherapy. It is specifically applied in treating ovarian, breast, and bladder cancers. As an injectable solution, it is administered via IV, intravesical, or intraperitoneal routes, making it a versatile option in modern cancer treatment protocols. Its neutral pH and odorless formulation ensure safe usage in both outpatient clinics and hospitals, providing effective, targeted therapy.
Market Reach and Delivery Details for Thiotepa Injection
The main domestic market for Thiotepa Injection is India, with an unparalleled presence among wholesalers, traders, and suppliers. Its main export markets include Asia, Africa, and select European regions. Delivery time is designed to minimize healthcare expenditure and optimize exchange productivity, typically within 714 business days. List price is competitive, ensuring affordability for institutions and practitioners worldwide while maintaining uncompromised quality standards.
FAQs of Thiotepa Injection:
Q: How should Thiotepa Injection be properly reconstituted and administered?
A: Thiotepa Injection must be reconstituted with sterile water for injection as per the instructions. It is administered through intravenous, intravesical, or intraperitoneal routes under strict medical supervision.
Q: What are the key precautions required during Thiotepa Injection handling and disposal?
A: Due to its cytotoxic nature, Thiotepa Injection should be handled with personal protective equipment (PPE) and disposed of according to established safety and environmental protocols for hazardous pharmaceutical waste.
Q: When should Thiotepa Injection not be used?
A: Thiotepa Injection is contraindicated in pregnancy and severe marrow suppression. Always consult medical guidelines and provider recommendations before use.
Q: Where are the batch number and expiry date displayed on Thiotepa Injection packaging?
A: The batch number is stamped on the packaging, while the expiry date is clearly printed, ensuring robust traceability and inventory management.
Q: What benefits do users gain from this preservative-free Thiotepa formulation?
A: The preservative-free formula minimizes adverse reactions and meets USP standards, delivering reliable efficacy and safety for patients undergoing chemotherapy treatments.
Q: What is the process for storing Thiotepa Injection after delivery?
A: Thiotepa Injection should be stored at 2C to 8C, protected from light, as per storage instructions provided on the packaging. Proper storage maintains potency and safety for up to two years.